Stock Evaluator
The Contrarian Way by Kaneki Kojo
HQLAbrdn Life Sciences Investors
Asset Management
Valuation Score
22.5/18
Share Price
$17.03
Balance Sheet Data(Source: Yahoo Finance | Currency: USD)
Book Value
(SH Equity)
$560.83M
Net Debt
-$75.54K
Free Cash Flow
$39.81M
Shares Outstanding
30.41M
EPS (Diluted)
$6.64
P/E Ratio
2.56
Mdn Growth Rate
(Net Income: 4yrs)
0.35%
Dividend Yield
13.35%
Payout Ratio
28.77%
Full Analysis & Price Charts
Sign in or register for free to view the complete valuation breakdown and historical price charts, including priced in gold chart.
Account Required
Sign in or create a free account to unlock the Analysis tool.
Disclaimer
- Capital at risk. The value of investments can go down as well as up. Past performance is not indicative of future results. This tool provides balance sheet analysis and does not constitute personal financial advice. Do your own due diligence.
- The score is backward-looking — it uses trailing twelve-month (TTM) data, not forward estimates.
- Sector differences are not adjusted for. Capital-intensive industries (e.g. airlines and utilities) naturally carry more debt and will score lower on debt metrics.
- The score does not account for management quality, competitive moats, or macro-economic conditions.
- It is designed as a screening tool, not a buy/sell recommendation. Always combine with qualitative research. The User is solely responsible for the outcome of their investments.